# Dual-Modality Immunotherapy for HPV Clearance (DUAL-HPV)

> **NCT07735039** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Dr. Lutfi Kirdar Kartal Training and Research Hospital** · enrollment: 76 (actual)

## Conditions studied

- Human Papillomavirus Infection
- Cervical Intraepithelial Neoplasia (CIN)
- Low-Grade Squamous Intraepithelial Lesions

## Interventions

- **DRUG:** Oral Immunomodulator
- **DRUG:** Vaginal Ovule
- **OTHER:** Standard Supportive Care

## Key facts

- **NCT ID:** NCT07735039
- **Lead sponsor:** Dr. Lutfi Kirdar Kartal Training and Research Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-04-28
- **Primary completion:** 2026-08-23
- **Final completion:** 2026-08-24
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2026-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07735039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07735039, "Dual-Modality Immunotherapy for HPV Clearance (DUAL-HPV)". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT07735039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*